Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

46.5K
Overview
46.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

511
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
511
Cancer Vaccines01:30

Cancer Vaccines

568
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
568
Development of Immunocompetence01:22

Development of Immunocompetence

516
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RSV nucleoprotein inhibitors in preclinical to phase II clinical development for respiratory syncytial virus infection.

Expert opinion on investigational drugs·2026
Same author

Evaluation of Probenecid Against Filovirus Replication in Vero E6 Cells.

Viruses·2026
Same author

Probenecid Treatment Inhibits Replication of the Edmonston Measles Virus Strain in Vero Cells.

Viruses·2025
Same author

Restricting O-Linked Glycosylation of the Mucin-like Domains Enhances Immunogenicity and Protective Efficacy of a Respiratory Syncytial Virus G Glycoprotein Vaccine Antigen.

Vaccines·2025
Same author

The MAPK Response to Virus Infection Is Modified by Probenecid.

Current issues in molecular biology·2025
Same author

Probenecid Inhibits NLRP3 Inflammasome Activity and Mitogen-Activated Protein Kinases (MAPKs).

Biomolecules·2025

Related Experiment Video

Updated: Oct 18, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K

Advances in Vaccine Development.

Ralph A Tripp1

  • 1Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.

Vaccines
|September 28, 2021
PubMed
Summary
This summary is machine-generated.

This special issue explores cutting-edge vaccine development, covering novel delivery systems, nanovaccines, and innovative platforms for enhanced immunogenicity and broader protection.

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K

Related Experiment Videos

Last Updated: Oct 18, 2025

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K

Area of Science:

  • Immunology and Microbiology
  • Biotechnology and Pharmaceutical Sciences

Background:

  • This special issue compiles recent research on vaccine development, addressing critical areas for improved efficacy and broader applicability.
  • It features articles, reviews, and perspectives on the latest scientific advancements in the field.

Discussion:

  • Explores innovations in vaccine delivery and expression systems, enhancing stability and targeted delivery.
  • Discusses the potential of nanovaccines for improved antigen presentation and immune response modulation.
  • Highlights research on novel epitopes, proteins, and adjuvants to optimize vaccine potency and safety.

Key Insights:

  • New vaccine platforms are emerging, offering alternative strategies to traditional methods.
  • Nanotechnology is revolutionizing vaccine design, enabling more effective antigen delivery and immune stimulation.
  • Understanding of epitopes and adjuvants is crucial for designing next-generation vaccines.

Outlook:

  • Continued advancements in vaccine platforms and delivery technologies promise more effective and accessible vaccines.
  • The integration of nanotechnology and rational antigen design will drive future vaccine innovation.
  • Future research will focus on developing universal vaccines and addressing emerging infectious diseases.